ADT40P1 induced neuritic plaque tau pathology indistinguishable from that induced by extracted AD-tau, suggesting that ADT40P1 could be used in lieu of AD-tau, which is a very limited resource, for further in vivo studies of tau pathogenesis. This evidence concerns the gene MAPT and Alzheimer disease.